STOCK TITAN

InfuSystem Holdings, Inc. - INFU STOCK NEWS

Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.

InfuSystem Holdings, Inc. (NYSE American: INFU) is a growing healthcare service provider specializing in delivering infusion pumps and related products and services to patients across the United States and Canada. The company is headquartered in Rochester Hills, Michigan, and operates from five strategically located facilities to ensure comprehensive coverage. InfuSystem facilitates outpatient care through a two-platform model: Patient Services and Device Solutions.

Patient Services offers a last-mile solution for clinic-to-home healthcare. This segment includes Oncology, Pain Management, Wound Therapy, and Lymphedema services. It focuses on delivering complex durable medical equipment directly to patients, ensuring they receive continuous care at home or other non-hospital settings.

Device Solutions supports the Patient Services platform by providing direct payer rentals, pump and consumable sales, and biomedical services and repair. This segment's goal is to enhance service orientation and secure additional business from its direct payer clients.

InfuSystem's innovative approach and strategic partnerships have made it a leader in the healthcare service sector. Recently, the company announced a sales and marketing partnership with Dignitana AB, a leader in scalp cooling technology. This collaboration allows InfuSystem to offer the FDA-cleared DigniCap Scalp Cooling System to help minimize hair loss for cancer patients undergoing chemotherapy. This partnership highlights InfuSystem's commitment to enhancing patient care and expanding its product offerings.

InfuSystem boasts a robust financial position, underpinned by its diversified service offerings and strong market presence. The company continues to explore new opportunities to grow and enhance its service delivery, ensuring that it remains at the forefront of the healthcare industry.

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced a national distribution agreement with Genadyne Biotechnologies, enhancing its portfolio in negative pressure wound therapy (NPWT). InfuSystem will distribute Genadyne’s complete line of wound care products, including the advanced XLR8 Plus NPWT Pump and XLR8 Dressing Kit with Silver. This partnership aims to address supply chain challenges and provide diverse wound care solutions, ultimately improving patient outcomes and reducing healthcare costs. InfuSystem emphasizes its commitment to facilitating outpatient care and enhancing service delivery in the durable medical equipment sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
none
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) reported record net revenues of $109.9 million for 2022, marking a 7% increase from 2021. The fourth quarter net revenues reached $28.8 million, a 9% year-over-year increase. Key segments include Integrated Therapy Services (ITS) with $68.9 million and Durable Medical Equipment (DME) at $41.0 million, growing 5% and 12% respectively. Adjusted EBITDA for 2022 was $20.7 million, down 14%. The company projects 2023 revenue growth of 8% to 10% with an Adjusted EBITDA margin over 19%. Management remains optimistic about strategic partnerships and growth in pain management services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.8%
Tags
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced it will release preliminary fourth quarter and full year 2022 financial results on March 15, 2023, before the market opens. A conference call will be held on the same day at 9:00 a.m. Eastern Time to discuss these results. The company operates through two platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services), providing comprehensive outpatient care. InfuSystem ensures local client support through its Centers of Excellence across several states and Ontario, Canada, enhancing its service delivery and operational efficiencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
conferences earnings
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU), a key provider of outpatient care for durable medical equipment, will participate in Craig-Hallum’s 13th Annual Alpha Select Conference on November 17, 2022, at the Sheraton New York Times Square. CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will be present for one-on-one meetings. InfuSystem operates under two platforms: Integrated Therapy Services and Durable Medical Equipment Services, serving various healthcare needs across the U.S. and Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
conferences
-
Rhea-AI Summary

InfuSystem Holdings reported record net revenues of $27.3 million for Q3 2022, up 3% year-over-year, with Integrated Therapy Services (ITS) revenues rising to $17.4 million, a 5% increase. Operating income increased by $1.3 million to $0.9 million, with net income of $0.4 million or $0.02 per diluted share. Gross profit also rose to $16.2 million, marking a 6% increase. The company projects full-year revenue at about $112 million, on the lower end of growth guidance of 10% to 13%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
-
Rhea-AI Summary

InfuSystem Holdings (INFU) and Sanara MedTech (SMTI) have formed a partnership called SI Wound Care to enhance wound care solutions. This collaboration aims to improve patient outcomes, reduce healthcare costs, and increase satisfaction for both patients and providers. InfuSystem plans to leverage its extensive distribution network as a participating in-network provider for over 95% of the U.S. population. The partnership will include Cork Medical’s negative pressure wound therapy devices and Sanara’s advanced product line, targeting both chronic and acute wounds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.82%
Tags
partnership
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced its third quarter 2022 financial results will be issued on November 8, 2022, before the market opens. A conference call will follow at 9:00 a.m. Eastern Time to discuss the financial outcomes. Interested parties can join by dialing (833) 366-1127 or via a live webcast on the company’s website. InfuSystem provides healthcare services focusing on outpatient care for durable medical equipment manufacturers, with operations across several U.S. states and Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.82%
Tags
conferences earnings
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) appointed R. Rimmy Malhotra as an independent director, effective September 20, 2022. Malhotra, who invested in the company in 2012, brings valuable insights on investments and capital allocation. His appointment is expected to enhance the company’s governance and strategic direction as it aims for long-term growth. Malhotra has extensive experience in investment and management, serving as Vice Chairman of HireQuest Inc. and on various other boards, complementing InfuSystem's focus on outpatient care for durable medical equipment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
management
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced participation in Lake Street Capital Markets' 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022, in New York City. CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will engage in one-on-one and group meetings with investors. The BIG6 Conference is an exclusive event that connects top public companies with institutional investors. InfuSystem specializes in outpatient care and durable medical equipment services, focusing on Integrated Therapy Services and Durable Medical Equipment Services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
conferences
Rhea-AI Summary

InfuSystem Holdings reported Q2 2022 net revenues of $27 million, marking a 9% increase year-over-year. Integrated Therapy Services (ITS) revenues grew 6% to $17.2 million, while Durable Medical Equipment (DME) revenues surged 15% to $9.8 million. Despite revenue growth, gross profit fell 1% to $14.9 million with a gross margin decline to 55.1%. The company posted a net loss of $0.2 million or $(0.01) per diluted share. Adjusted EBITDA was $5.5 million, a 6% decrease. Full-year revenue guidance was revised to 10%-13% growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.34%
Tags

FAQ

What is the current stock price of InfuSystem Holdings (INFU)?

The current stock price of InfuSystem Holdings (INFU) is $8.31 as of December 20, 2024.

What is the market cap of InfuSystem Holdings (INFU)?

The market cap of InfuSystem Holdings (INFU) is approximately 169.2M.

What services does InfuSystem Holdings, Inc. provide?

InfuSystem provides infusion pumps and related services to patients at home, in oncology clinics, ambulatory surgery centers, and other care sites.

What are the two platforms of InfuSystem's services?

InfuSystem operates through Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which provides rentals, sales, and biomedical services.

Where is InfuSystem Holdings, Inc. headquartered?

InfuSystem Holdings, Inc. is headquartered in Rochester Hills, Michigan.

Who are InfuSystem's recent partners?

InfuSystem recently partnered with Dignitana AB to offer the DigniCap Scalp Cooling System, which helps minimize hair loss during chemotherapy.

What is the DigniCap Scalp Cooling System?

The DigniCap Scalp Cooling System is an FDA-cleared device designed to reduce hair loss in cancer patients undergoing chemotherapy.

What areas does InfuSystem serve?

InfuSystem serves patients across the United States and Canada.

What is the objective of the Patient Services platform?

The Patient Services platform aims to provide comprehensive clinic-to-home healthcare solutions, ensuring continuous care for patients using complex durable medical equipment.

How does the Device Solutions platform support InfuSystem?

Device Solutions enhances the Patient Services platform by offering direct payer rentals, pump and consumable sales, and biomedical services and repair.

What are InfuSystem's business segments?

InfuSystem's business segments include Oncology, Pain Management, Wound Therapy, and Lymphedema under Patient Services, and rentals, sales, and repair services under Device Solutions.

How does InfuSystem contribute to patient care?

InfuSystem ensures patients receive necessary medical equipment and services at home, improving their quality of life and enabling continuous treatment outside of hospital settings.

InfuSystem Holdings, Inc.

NYSE:INFU

INFU Rankings

INFU Stock Data

169.15M
20.01M
6.07%
78.98%
0.88%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
ROCHESTER HILLS